Shares of Viatris Inc. VTRS shed 1.81% to $8.68 Friday, on what proved to be an all-around dismal trading session for the ...

Shares of Viatris Inc. slipped 3.76% to $8.95 Tuesday, on what proved to be an all-around favorable trading session for the ...

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Viatris Inc. (“Viatris” or the “Company”) ( ...

NEW YORK, NY / ACCESS Newswire / March 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc.

Appeals court upholds J&J win blocking Mylan's generic version of schizophrenia drug Invega Trinza, protecting patent for ...

We recently published a list of 10 Best Stocks to Buy According to Billionaire David Einhorn. In this article, we are going ...

Viatris Inc. closed 31.37% below its 52-week high of $13.55, which the company reached on November 25th.

Viatris Inc. (NASDAQ: VTRS), a global healthcare company, will present at the Barclays 27th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, March 11, 2025. The company's ...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Viatris Inc. (“Viatris” or the “Company”) (NASDAQ: VTRS) investors concerning the ...

Free cash flow rose to $685 million, marking a 26.1% increase year-over-year. Viatris reported mixed results for Q4 2024, missing revenue and EPS expectations, despite noteworthy debt reduction ...

PITTSBURGH, Feb. 27, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that on February 24, 2025, its Board of Directors approved a 2025 dividend policy of 48 cents ($0.48 ...

Viatris is taking a hard look at its operations worldwide. Find out why the company's CEO thinks now is the perfect time for change. STORY HIGHLIGHTS Viatris launches companywide review of global ...